Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria

被引:1
作者
Onwujekwe, Obinna [2 ,3 ]
Orjiakor, Charles [2 ,4 ,5 ]
Ogbozor, Pamela [2 ,6 ]
Agu, Ifunanya [2 ]
Agwu, Prince [2 ,7 ]
Wright, Tom [9 ]
Balabanova, Dina [8 ]
Kohler, Jillian [1 ]
机构
[1] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
[2] Univ Nigeria, Coll Med, Dept Pharmacol & Therapeut, Hlth Policy Res Grp, Enugu, Nigeria
[3] Univ Nigeria, Dept Hlth Adm & Management, Nsukka, Enugu, Nigeria
[4] Univ Nigeria, Dept Psychol, Nsukka, Nigeria
[5] Univ Toronto, Dept Psychol, Scarborough, ON, Canada
[6] Enugu State Univ Sci & Technol, Dept Psychol, Enugu, Nigeria
[7] Univ Nigeria, Dept Social Work, Nsukka, Nigeria
[8] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England
[9] Transparency Int, Transparency Int Global Hlth Programme, London, England
关键词
Accountability; Coronavirus; Corruption; COVAX; COVID-19; Transparency; Vaccines;
D O I
10.1186/s40545-023-00649-7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundPublic health emergencies raise significant concerns about corruption and accountability; however, these concerns can manifest in different ways across diverse locations. For instance, more developed countries with a stronger rule of law may experience more corruption in vaccine procurement, whereas developing countries may experience more corruption at the point of distribution and delivery to end users. This research focuses on corruption concerns in Nigeria, specifically examining the procurement and distribution of COVID-19 vaccines.MethodsThis paper utilizes a scoping review and a qualitative research approach. Key informants (n = 40) involved in the procurement and distribution of COVID-19 vaccines across two states in Nigeria were interviewed. Findings from the scoping review were summarized, and collected data were inductively coded and analysed in themes, revealing clear examples of implementation irregularities and corruption in the country's COVID-19 vaccination processes.ResultsVaccination programme budgeting processes were unclear, and payment irregularities were frequently observed, resulting in vaccinators soliciting informal payments while in the field. Recruitment and engagement of vaccination personnel was opaque, while target vaccination rates incentivized data falsification during periods of vaccine hesitancy. Accountability mechanisms, such as health worker supervision, vaccination data review, and additional technical support provided by donors were implemented but not effective at preventing corruption among frontline workers.ConclusionsFuture accountability measures should be evidence-driven based on findings from this research. Personnel recruitment, contracting, budgeting, and remuneration should focus on transparency and accountability.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] COVID-19 vaccines for patients with cancer: benefits likely outweigh risks
    Hwang, Joyce K.
    Zhang, Tian
    Wang, Andrew Z.
    Li, Zihai
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [22] The societal economic value of COVID-19 vaccines in the United States
    Kirson, Noam
    Swallow, Elyse
    Lu, Jessica
    Mesa-Frias, Marco
    Bookhart, Brahim
    Maynard, Josie
    Shivdasani, Yashna
    Lefebvre, Patrick
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 119 - 128
  • [23] Distribution of Vaccines During a Pandemic (Covid-19)
    Dhanapal, Vignesh
    Sarin, Subhash C.
    [J]. ADVANCES IN PRODUCTION MANAGEMENT SYSTEMS: ARTIFICIAL INTELLIGENCE FOR SUSTAINABLE AND RESILIENT PRODUCTION SYSTEMS, APMS 2021, PT IV, 2021, 633 : 39 - 48
  • [24] Allergen immunotherapy, COVID-19 infection and COVID-19 vaccines
    Jutel, Marek
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 19 - 19
  • [25] COVID-19 Vaccines and COVID-19 in People Living with HIV
    Karasin, Muhammed Fatih
    Bayraktar, Zeynep
    Toygar-Deniz, Muge
    Akhan, Sila
    Ozdemir, Mehmet Kagan
    [J]. INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2024, 6 (02): : 78 - 82
  • [26] Planning for COVID-19 vaccines safety surveillance
    Kochhar, Sonali
    Salmon, Daniel A.
    [J]. VACCINE, 2020, 38 (40) : 6194 - 6198
  • [27] Recent Advances on Drugs and Vaccines for COVID-19
    Peng, Fang
    Yuan, Hao
    Wu, Sixian
    Zhou, Yifeng
    [J]. INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2021, 58
  • [28] Adjuvants for COVID-19 Vaccines
    Castrodeza-Sanz, Javier
    Sanz-Munoz, Ivan
    Eiros, Jose M.
    [J]. VACCINES, 2023, 11 (05)
  • [29] COVID-19 Vaccines in Children
    Fayad, Danielle
    Frenck, Robert W.
    Tan, Tina Q.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [30] COVID-19 vaccines and myocarditisVaccins
    Kerneis, Mathieu
    Bihan, Kevin
    Salem, Joe-Elie
    [J]. ARCHIVES OF CARDIOVASCULAR DISEASES, 2021, 114 (6-7) : 515 - 517